The widespread suppression of E2F-responsive genes, regardless of genetic heterogeneity among cell lines, suggests that the E2F transcriptional program is a primary target of BET inhibition in HPV-positive HNSCC. The gene discussed is DNER; the disease is head and neck squamous cell carcinoma.